COWN Stock Recent News

BETHESDA, Md. , Sept. 30, 2024 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) today announced that management are scheduled to participate in TD Cowen's 2024 Nuclear Fuel & Next Generation Virtual Roundtable on October 8.

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate virtually in a fireside chat at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit on Thursday, September 26, 2024, at 8:40 a.m. ET.

SAN DIEGO , Sept. 19, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit at 11:00 a.m.

Restaurant Business Magazine's Jonathan Maze and TD Cowen's Andrew Charles, join McDonald's extending its value meal and the state of the quick service and fast casual sectors.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE: BFA, BFB) announced today that President and Chief Executive Officer Lawson Whiting will participate in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit on September 17, 2024. Brown-Forman's virtual “fireside chat” will begin at approximately 11:00 a.m. (EDT) and will be available as a webcast on the Brown-Forman website at brown-forman.com on the Investors/Events & Presentations page. A replay will be available on the Bro.

CORAL GABLES, Fla.--(BUSINESS WIRE)--Fresh Del Monte Produce Inc. Announces Participation in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit.

Andrew Charles, TD Cowen research analyst, joins 'Money Movers' to discuss the similarities between Brian Niccol's position with Starbucks now and Chipotle some years ago, how Niccol was able to impact Chipotle, and more

Dan Brennan, senior analyst at TD Cowen, joins CNBC's 'The Exchange' to discuss his price target on Tempus, AI in diagnostics, and more.

Ritu Baral, TD Cowen Sr. Biotechnology Analyst, joins 'Closing Bell Overtime' to talk Sarepta's approval from the FDA for its Duchenne gene therapy and how it drove the stock to its best trading day in a year.

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate in the TD Cowen Genetic Medicines & RNA Summit on Friday, June 21, 2024, at 11:20 am ET.